We are live on ! Find out more
DCOY

Decoy Therapeutics
DCOY

15 hedge funds and large institutions have $1.45M invested in Decoy Therapeutics in 2022 Q1 according to their latest regulatory filings, with 2 funds opening new positions, 0 increasing their positions, 3 reducing their positions, and 4 closing their positions.

New
Increased
Maintained
Reduced
Closed

0% less ownership

Funds ownership: 0% → 0% (-0%)

12% less funds holding

Funds holding: 17 → 15 (-2)

45% less capital invested

Capital invested by funds: $2.63M → $1.45M (-$1.18M)

50% less first-time investments, than exits

New positions opened: 2 | Existing positions closed: 4

100% less repeat investments, than reductions

Existing positions increased: 0 | Existing positions reduced: 3

Holders
15
Holders Change
-2
Holders Change %
-11.76%
% of All Funds
0.24%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
2
Increased
–
Reduced
3
Closed
4
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
Cambridge Investment Research Advisors
Cambridge Investment Research Advisors
Iowa
+$15.8K
2
VF
Virtu Financial
New York
+$15.8K

Top Sellers

Rank Fund Capital Flow
1
SCM
Sio Capital Management
New York
-$671K
2
Renaissance Technologies
Renaissance Technologies
New York
-$47.3K
3
Two Sigma Advisers
Two Sigma Advisers
New York
-$47.3K
4
Two Sigma Investments
Two Sigma Investments
New York
-$45K
5
1WM
1900 Wealth Management
Texas
-$20K

DCOY Hedge Fund Activity: Q1 2022 in Review

15 of the 6,360 institutional investors tracked by Wall St. Rank reported a position in Decoy Therapeutics (DCOY) for Q1 2022, worth a combined $1.45M — down 45% from $2.63M a quarter earlier.

Sellers outnumbered buyers: 4 funds closed out of DCOY and 2 opened new positions — a net loss of 2 holders — while 3 trimmed existing stakes and 0 added.

The largest buyer was Cambridge Investment Research Advisors, opening a new position worth an estimated $15.8K. The largest seller was Sio Capital Management, exiting entirely with an estimated $671K sold.

  • 15 institutional investors held Decoy Therapeutics (DCOY) as of Q1 2022, down from 17 in Q4 2021.
  • Funds reported $1.45M of Decoy Therapeutics stock for Q1 2022, down 45% quarter-over-quarter.
  • 2 funds opened new Decoy Therapeutics positions in Q1 2022 and 4 closed out, a net change of -2 holders.
  • The largest Decoy Therapeutics buyer in Q1 2022 was Cambridge Investment Research Advisors, an estimated $15.8K added.
  • The largest Decoy Therapeutics seller in Q1 2022 was Sio Capital Management, an estimated $671K sold.

Based on aggregated 13F filings for Q1 2022.